SCHEMBL29780104

SCHEMBL29780104

O=S(=O)(Oc1cc(Cl)ccc1-c1cnn(C(F)F)c1)C(F)(F)F

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CHRM1 P11229 2/20 0.41
▸ CHRM2 P08172 1/20 0.41
▸ RRM1 P23921 1/20 0.41
▸ RRM2B Q7LG56 1/20 0.41
▸ SCN9A Q15858 2/20 0.41
▸ FPR2 P25090 1/20 0.40
▸ PDE3B Q13370 4/20 0.39
▸ PDE3A Q14432 4/20 0.39
▸ F11 P03951 6/20 0.39
▸ KLKB1 P03952 4/20 0.39
▸ DRD2 P14416 1/20 0.35
▸ DRD4 P21917 1/20 0.35
▸ DRD3 P35462 1/20 0.35
▸ PDE4A P27815 1/20 0.35
▸ PDE4C Q08493 1/20 0.35
▸ PDE4D Q08499 1/20 0.35
▸ KLK1 P06870 1/20 0.34
▸ GRM2 Q14416 2/20 0.33
▸ CREBBP Q92793 1/20 0.33
▸ CCNC P24863 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18797533 1.00 CHRM1 (0.41) CHRM1CHRM2RRM1RRM2BSCN9A
SCHEMBL18797473 0.73 FPR2 (0.43) CHRM1CHRM2RRM1RRM2BSCN9A
SCHEMBL16983106 0.72 FPR2 (0.40) CHRM1CHRM2RRM1RRM2BSCN9A
SCHEMBL20360209 0.72 FPR2 (0.40) CHRM1CHRM2RRM1RRM2BSCN9A
SCHEMBL30702150 0.72 FPR2 (0.40) CHRM1CHRM2RRM1RRM2BSCN9A
SCHEMBL31132006 0.71 PIK3CD (0.35) PDE3BPDE3ACREBBP
SCHEMBL17661863 0.70 PDE3B (0.42) CHRM1CHRM2RRM1RRM2BSCN9A
SCHEMBL31131553 0.70 SYK (0.53) SCN9A
SCHEMBL8500197 0.68 EPAS1 (0.40) CHRM1DRD2DRD4DRD3PDE4A
SCHEMBL24428326 0.68 RET (0.47) SCN9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3368036-B1 MACROCYCLIC PYRIDINE-N-OXIDE DERIVATIVES AS FACTOR XIA INHIBITORS MERCK SHARP & DOHME LLC (US) 2022-07-20 — — EP disclosed
Send feedback